b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">32275930</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1879-2596</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>1867</Volume>\n                    <Issue>9</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Sep</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Biochimica et biophysica acta. Molecular cell research</Title>\n                <ISOAbbreviation>Biochim Biophys Acta Mol Cell Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>BAG5 promotes invasion of papillary thyroid cancer cells via upregulation of fibronectin 1 at the translational level.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>118715</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0167-4889(20)30073-2</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbamcr.2020.118715</ELocationID>\n            <Abstract>\n                <AbstractText>Papillary thyroid cancer (PTC), the most common thyroid malignancy, has a strong propensity for neck lymph node metastasis, which will increase the risk of local recurrence and decrease the survival in some high-risk groups. Hence, it is essential to set up a reliable biomarker to predict lymph node metastasis. BAG5 is a unique member of the BAG cochaperone family because it consists of more than one BAG domain, which acts as modulator of chaperone activity. In this study, we found that expression of BAG5 was significantly increased in PTC cells and tissues. Neither overexpression nor downregulation of BAG5 altered the proliferation of PTC cells. On the contrary, overexpression of BAG5 significantly promoted, while knockdown of BAG5 significantly decreased migration and invasion of PTC cells. Along with this, fibronectin 1 (FN1) was significantly increased and decreased in cells that overexpress or downregulate BAG5, respectively. Mechanistically, we found that BAG5 modulated FN1 expression at the translational level and promoted invasion via suppression of miR-144-3p, which targeted the 3\' untranslational region (UTR) of FN1 transcript. This study suggests that BAG5 is an important regulator of migration and invasion in PTC cells and may represent a novel therapeutic target for intervening in PTC progression.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2020. Published by Elsevier B.V.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Da-Lin</ForeName>\n                    <Initials>DL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biochemistry &amp; Molecular Biology, China Medical University, Shenyang 110122, China; Key Laboratory of Cell Biology, Ministry of Public Health, Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China; Department of Thyroid Surgery, The 1st Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Jia-Mei</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Medical Laboratory, The 1st Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wu</LastName>\n                    <ForeName>Tong</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology &amp; Metabolism, The 1st Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Du</LastName>\n                    <ForeName>Xin</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology &amp; Metabolism, The 1st Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yan</LastName>\n                    <ForeName>Jing</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biochemistry &amp; Molecular Biology, China Medical University, Shenyang 110122, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Du</LastName>\n                    <ForeName>Zhen-Xian</ForeName>\n                    <Initials>ZX</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology &amp; Metabolism, The 1st Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Hua-Qin</ForeName>\n                    <Initials>HQ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biochemistry &amp; Molecular Biology, China Medical University, Shenyang 110122, China; Key Laboratory of Cell Biology, Ministry of Public Health, Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China. Electronic address: hqwang@cmu.edu.cn.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>04</Month>\n                <Day>08</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>Biochim Biophys Acta Mol Cell Res</MedlineTA>\n            <NlmUniqueID>101731731</NlmUniqueID>\n            <ISSNLinking>0167-4889</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">BAG5</Keyword>\n            <Keyword MajorTopicYN="N">Fibronectin 1</Keyword>\n            <Keyword MajorTopicYN="N">Papillary thyroid cancer</Keyword>\n        </KeywordList>\n        <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2020</Year>\n                <Month>04</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32275930</ArticleId>\n            <ArticleId IdType="pii">S0167-4889(20)30073-2</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.bbamcr.2020.118715</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'